Abstract
The activation of genetic constructs including the Drosophila hsp70 promoter with four and eight HSE sequences in the regulatory region has been described in human cells. The promoter was shown to be induced at lower temperatures compared to the human hsp70 promoter. The promoter activity increased after a 60-min heat shock already at 38°C in human cells. The promoter activation was observed 24 h after heat shock for the constructs with eight HSEs, while those with four HSEs required 48 h. After transplantation of in vitro heat-shocked transfected cells, the promoter activity could be maintained for 3 days with a gradual decline. The promoter activation was confirmed in vivo without preliminary heat shock in mouse ischemic brain foci. Controlled expression of the Gdnf gene under a Drosophila hsp70 promoter was demonstrated. This promoter with four and eight HSE sequences in the regulatory region can be proposed as a regulated promoter in genetic therapeutic systems.
Introduction
Gene and cell therapy opens up new opportunities for treating neurological diseases. However, despite considerable advances in this field, the progress in clinical practice is still limited. Among other things, this is due to insufficient choice of promoters for therapeutic genes. The downside of gene therapeutic systems is insufficient regulation of gene expression, which makes it difficult to maintain their expression at the level required for the healing effect. Widely used cytomegalovirus (CMV) promoter proved to have highly variable activity in different tissues [1]. It is nearly inactive in undifferentiated mammalian embryonic cells [2]. Application of ubiquitin promoters does not allow transgene expression to be limited to desired cell population or tissue. Ectopic expression of exogenous genes can have dangerous side effects including inflammation and immune responses [3]. Inducing agent toxicity as well as the immune response to chimeric transactivators in the case of transcription factors activated by small molecules (e.g., tetracycline-activated systems) prevents their clinical application [4], [5], [6]. This substantiates the discovery of new regulated promoters.
A regulated promoter activated without inducing agents can be exemplified by the heat shock protein promoter. The hsp70 promoter is activated by increased temperature alone. However, the mammalian hsp70 promoter is induced by body temperature increase to 42°C, which is traumatic for mammalian cells. The hsp70 promoter in Drosophila melanogaster is activated in insect cells at 37°C. System with such properties could be highly convenient in cell therapy since human/mammalian body temperature can directly stimulate the Drosophila heat shock protein promoter [7]. Previously, we have shown that the introduction of the Drosophila melanogaster hsp70 promoter into mammalian cells changes its activation temperature to 39–40°C, which is higher than the normal mammalian body temperature (37°C) but lower than the activation temperature of the mammalian hsp70 promoter (42°C) and further from the upper limit of the physiological temperature range [8]. Apart from high temperature, hsp70 promoter can be activated by a variety of other stress stimuli including hypoxia [9], ischemia [10], and infection [11]. In this context, a therapeutic gene can be activated in transgenic cells injected into an ischemic focus or other pathological area with inflammation. Thus, further studies of the regulatory regions of hsp70 promoter are relevant to elucidate the mechanisms underlying its regulation and to apply this promoter in the development of gene therapeutic constructs.
The Drosophila hsp70 promoter can be activated in mouse and monkey cells as well as in Xenopus oocytes [12]. The promoter activation is mediated by the interaction between the heat shock factor (HSF) and heat shock element (HSE) [13]. The prepromoter region of the Drosophila hsp70 gene contains four HSEs, each of which includes three or four 5-bp sequences 5′-NGAAN-3′ [14], [15]. The Drosophila hsp70 promoter can also be heat shock-activated in yeasts, mouse cells, monkey COS cells, and Xenopus oocytes [12]. Yeast transfection by the construct with β-galactosidase gene under control of the Drosophila hsp70 promoter with different modifications of the regulatory region demonstrated that stable promoter activation requires two or more sequences composed of 5′-NGAAN-3′ and complementary 5′-NTTCN-3′ pentamers. The promoter inducibility increases with the number of such sequences [16]. Such strong cooperativity of binding HSEs by HSF assumes that the heat shock gene expression depends both on the length and number of HSEs [17].
The present work studied the functional properties of the Drosophila hsp70 promoter with different numbers of HSEs (four and eight) in the regulatory region in human cells. The temperature range as well as the effect of HSEs in the regulatory region on the promoter activation were determined. After transplantation of in vitro heat-shocked transfected cells into the mouse brain, the promoter activity could be maintained for 3 days with a gradual decline. The promoter activation in vivo without preliminary heat shock was confirmed in mouse ischemic brain foci. Controlled expression of the GDNF gene under a Drosophila hsp70 promoter was demonstrated.
Materials and Methods
Plasmid Constructs
Two vectors B7 and F7 (Figs. 1, 2) were generated to study the regulated promoter of the Drosophila melanogaster hsp70 gene. All constructs were based on pEGFP-N1 (GenBank Acc. # U55762) and pCaSpeR-hs/act (GenBank Acc. # U60735) vectors. The HindIII/EcoRI fragments (553 and 953 bp) containing the hsp promoter (453 bp) and the regulatory region of 100 bp (four HSEs) (B7) or 500 bp (eight HSEs) (F7) were used for the study. The fragments were generated by PCR from the pCaSpeR-hs/act plasmid using the following primers: Casp1F, 5′-gatcaagcttgttcaatgatatccagtgc-3′; Casp5F, 5′-cccaaagcttggatttttcacactttcccc-3′; and CaspR, 5′-taacgaattcccaattccctattcag-3′. Casp1 and Casp5 were generated by pCaSpeR-hs/act digestion with EcoRI. The resulting fragments were sequenced to confirm their authenticity and cloned into EcoRI-digested pGEM-T Easy vector (Promega #1360) following the manufacturer's protocol. The resulting constructs pGEM/Casp1 and pGEM/Casp5 were digested with HindIII and EcoRI and the 553 and 953 bp fragments were cloned into the corresponding sites of the EGFP-N1 vector, respectively. The authenticity of the F7(pEGFP-N/Casp1) and F7(pEGFP-N1/Casp5) vectors was confirmed by restriction endonuclease analysis and sequencing. These vectors contain the gfp gene as a marker and the neomycin resistance gene, which allows G418-selection of the transfectants.
The B7 and F7 vectors were used to engineer two constructs containing the glial cell line-derived neurotrophic factor (Gdnf) gene. Human Gdnf gene was chemically synthesized using the sequence from the UniProtKB (first isoform of P39905) (Evrogene). The Gdnf gene fragment of 650 bp was amplified by PCR using primers T3(F) 5′-attaaccctcactaaaggga-3′ and Gdnf BamH1 5′-tggatcccagatacaccacaccttttagcgg-3′ and cloned into the pGEM-T Easy vector (Promega #1360) following the manufacturer's protocol. The authenticity of the resulting pGEM/Gdnf construct was confirmed by EcoRI endonuclease analysis and sequencing. The 600 bp EcoRV/BamHI fragment of pGEM/Gdnf containing the Gdnf gene was cloned into the EcoRV and SmaI sites of B7 and F7 using the Klenow fragment (Fermentas). The authenticity of the resulting constructs B7/Gdnf/gfp and F7/Gdnf/gfp was confirmed by restriction endonuclease analysis and sequencing.
Cell Cultures and Transfection
Cells HEK293 were cultured in 25 cm2 flasks (Costar) with DMEM (PanEko) supplemented with 10% fetal calf serum (Perbio HyClone), 4 mg/ml L-glutamine (PanEko), and 4% gentamicin (PanEko) in a CO2 incubator at 37°C and 5% CO2. The cells (1.5×105 cells/ml) were transfected with the B7 or F7 vectors using ExGene 500 (Termo Scientific, R0511). The transfected clones were selected with 0.4 mg/mm geneticine (G418, Invitrogen # 15750045) for 10 days, after which he RNA was isolated from G418-resistant clones for RT-PCR analysis. As a result, the following transgenic cell cultures were established: HEK293/B7/gfp, HEK293/F7/gfp, HEK293/B7/Gdnf/gfp, and HEK293/F7/Gdnf/gfp.
Reverse Transcription Polymerase Chain Reaction
Cultured cells were harvested from flasks using trypsin and Versene (PanEko). RNA isolated from transgenic cell cultures was used for RT-PCR. RNA was isolated using Trisol reagent (Sigma). Reverse transcription was performed in the reaction mixture containing 5 µg RNA, 0.5 µg oligo(dT), and 20 µl H20 using a BioRad amplifier. cDNA was synthesized from single-stranded RNA using a RevertAid Reverse Transcriptase (M-MuLV RT) (Termo Scientific) using the following program: 70°C, 5 min; 37°C, 60 min; 70°C, 5 min; and 20°C, 30 s. The synthesized cDNA was used in PCR with the following primer pairs: neo(R) 5′-tcagaagaactcgtcaagaa-3′ and neo(F) 5′-atgattgaacaagatggatt-3′, 795 bp PCR product; GAPDH(R) 5′-cccctggccaaggtcatccatgacaactt-3′ and GAPDH(F) 5′-ggccatgaggtccaccaccctgttgctgta-3′, 513 bp product; Gdnf(F) 5′-ggaatcggcaggctgcagctg-3′ and gfp(R) 5′-aataaagcttgcatggcggtaatacg-3′, 1211 bp product; gfp(F) 5′-cgtcagatccgctagcgctaccgg-3′ and gfp(R) 5′- aataaagcttgcatggcggtaatacg-3′, 715 bp product. The PCR program consisted of 94°C for 2 min; 30 cycles of 93°C for 10 s, 58°C for 20 s, and 72°C for 30 s; and final 72°C for 10 min.
In vitro Promoter Activation
Promoter activation was tested in transgenic cells HEK293/B7/gfp and HEK293/F7/gfp after heat shock. The cells were plated on 30 mm dishes at 70–80% confluency, exposed to temperatures from 37 to 42°C for 60 min, and placed back to normal culture conditions. GFP expression was examined 24 and 48 h after heat shock under an Olympus IX81 microscope or using a FACScan flow cytometer (Becton Dickinson) in green FL1 channel. In the latter case cells were rinsed twice with PBS and fixed with 2% formaldehyde in PBS at 4°C for 20 min. Four days after heat shock, a fraction of cells was exposed to heat shock again. Promoter activation in transgenic cells HEK293/B7/Gdnf/gfp and HEK293/F7/Gdnf/gfp was tested in a similar way.
Behavior of Transfected Cells Injected into Mouse Brain
Transgenic cells HEK293/B7/gfp and HEK293/F7/gfp as well as HEK293/B7/Gdnf/gfp, and HEK293/F7/Gdnf/gfp were injected into the striatum of Black-6 mice. Animals anesthetized by chloral hydrate were placed in a stereotaxic frame. A suspension containing about 100,000 cells in 1 µl of Hanks solution was gradually injected with a microsyringe into the right cerebral hemisphere at coordinates AP 0 mm and ML 2.5 mm. Transgenic cells HEK293/B7/gfp, and HEK293/F7/gfp were injected after pre-injection of 1 µg of endothelin-1 in 1 µl saline for 10 min into the same site. The needle was inserted to a depth of 2.5 mm and withdrawn in steps to a depth of 1.5 mm. After 3–5 days, the animals were anesthetized again and perfused through the heart with PBS and then with 4% formaldehyde in PBS. The brain was isolated, fixed again in formaldehyde for 12 h at 4°C, and soaked in 30% sucrose in PBS. The cryotome coronal sections of the brain (40 µm) were analyzed using an Olympus microscope IX81 optimized for GFP visualization. Cells were counted using the CellP software (Olympus Soft Imaging Solution GmbH).
Statistical Analysis
Data are presented as SEM ± SD. The statistical analysis was performed using the SPSS software. GFP-positive cell counts were averaged for each group and compared by one-way ANOVA followed by Tukey's multiple comparisons test. Statistical significance was accepted at P<0.05.
The study was approved by the Ethics Committee of Moscow State University (Permit Number 24-01). It was carried out in strict accordance with the ethical principles and scientific standards of the Ethics Committee of Moscow State University.
Results
Generation of Genetic Constructs
Regulated Drosophila melanogaster hsp70 promoter induced by heat shock was used in this work. Two vectors with different regulatory regions of the promoter were synthesized. One of them (B7) includes 100 bp (with four regulatory HSE sequences) upstream of the promoter, and the other vector (F7) includes 500 bp (with eight HSEs). Different amounts of the transcription factor HSF required for the promoter activation can be expected to bind the regulatory regions of these factors. The vectors contain the gfp gene as an expression marker and the neomycin resistance gene, which allows G418-selection of the transfectants. The HindIII-EcoRI fragments containing the hsp70 promoter and the regulatory region with the 100 and 500 bp sequences were isolated from the pCasper-hs-act vector. The subfragments amplified by PCR using specific primers hsR (5′-taacgaattcccaattccctattcag-3′), phs1F (5′-gatcaagcttgttcaatgatatccagtgc-3′), and phs5F (5′-cccaaagcttggatttttcacactttcccc-3′) were cloned into pGEM-T Easy (Promega, # 1360). HindIII-EcoRI fragments ‘hsp70+100 upstream’ and ‘hsp70+500 upstream’ were isolated from the resulting vectors, respectively (Fig. 1).
Constructs Containing gfp Gene under Control of Drosophila hsp70 Promoter
These fragments were cloned into the HindIII and EcoRI sites of the pEGFP-N1 vector. The authenticity of these constructs was confirmed by restriction endonuclease analysis and sequencing. The resulting vectors B7 and F7 contained the Drosophila hsp70 promoter, polylinker sequence, and gfp gene as a visual marker (Fig. 2, 3). B7 contains four HSEs in the promoter regulatory region, while F7 has eight HSE sequences (Fig. 2).
Isolated and purified B7 and F7 were introduced into HEK293 cells by transfection using ExGene 500 (Fermentas, R0511). PCR analysis of the total DNA isolated from HEK293 transgenic cells has confirmed the presence of the gfp gene in their genome. PCR was performed using primers gfpF (5′-cgtcagatccgctagcgctaccgg-3′) and gfpR (5′-aataaagcttgcatggcggtaatacg-3′) and the following profile: 94°C for 2 min; 30 cycles of 93°C for 10 s, 58°C for 20 s, and 72°C for 30 s; and final 72°C for 10 min.
Proteins isolated from the transgenic cultures were separated by SDS-PAGE (10%) and analyzed by Western blot. Rabbit polyclonal anti-GFP antibodies and secondary horseradish peroxidase-conjugated anti-rabbit secondary antibodies were used. Peroxidase complexes were detected using an ECL reagent. Thus, the constructs presence in cells has been confirmed (Fig. 4).
After G418-selection for 10 days and 24 h incubation in full medium, transfected cells were exposed to heat shock at temperatures from 38 to 42°C for 60 min. Control cells were not exposed to heat shock.
Fluorescent microscopy indicated a small number (up to 7%) of cells expressing the marker protein in transfected cells. Twenty-four hours after heat shock at 42°C, the culture transfected with the F7 vector (eight HSEs + hsp70 promoter) demonstrated a much higher proportion of GFP-expressing cells compared to those transfected with B7 (Fig. 5).
A notable increase in the background GFP expression was observed in cells transfected with F7 but not in those transfected with B7 24 h after heat shock at 40°C. Flow cytometry experiments tested the effect of heat shock at 40 and 42°C 24 and 48 h after heat shock (Fig. 6A). In F7-transfected culture, the proportion of GFP-expressing cells increased to 23% 24 h after heat shock at 40°C and to almost 40% after heat shock at 42°C. The proportion of GFP-expressing cells remained largely unaltered 48 h after heat shock. B7-transfected cell culture demonstrated a substantial increase in the proportion of GFP-expressing cells only 48 h after heat shock at 42°C.
Thus, the Drosophila hsp70 promoter in the B7 construct with four HSEs is activated at the same temperatures as the hsp70 promoter in mammalian cells. At the same time, the promoter in the F7 construct with eight HSEs is substantially activated at lower temperatures as well.
A more thorough investigation of the heat shock effect on the promoter activation demonstrated an increased proportion of GFP-expressing cells transfected with the F7 vector as early as 24 h after heat shock at 38°C and higher (Fig. 7). The cells transfected with B7 demonstrated a similar response only 48 h after heat shock at 40°C and higher.
Preliminary experiments demonstrated that the number of GFP-expressing cells decreases to the background level 96 h after the first heat shock. However, second heat shock reactivated the promoter and the synthesis of the marker protein.
Constructs Containing glial cell line-derived neurotrophic factor (Gdnf) gene under control of drosophila hsp70 promoter
B7 and F7 vectors were used to engineer the constructs containing the Gdnf gene under control of Drosophila hsp70 promoter. PCR fragment (amplified using primers T3 (5′-attaaccctcactaaaggga-3′) and Gdnf-BamHI (5′-tggatcccagatacatccacaccttttagcgg-3′) was cloned into pGEM-T Easy. The authenticity of the pGEM-T/Gdnf construct was confirmed by restriction endonuclease analysis, PCR, and sequencing. The EcoRV-BamHI fragment of the Gdnf gene (600 bp) of this plasmid was cloned into SmaI and BamHI sites of B7 and F7. The authenticity of the resulting constructs was confirmed by restriction endonuclease analysis and PCR analysis using primers Gdnf-F (5′-ggaatcggcaggctgcagctg-3′) and gfp-R (5′-aataaagcttgcatggcggtaatacg-3′) (Fig. 8). In addition, they were sequenced using primers Gdnf-F (5′-ggaatcggcaggctgcagctg-3′) and Gdnf-R (5′-aatgctttcttagaatatggt-3′). The diagrams of the genetic constructs are shown in Fig. 9.
Isolated and purified B7/Gdnf/gfp and F7/Gdnf/gfp were introduced into HEK293 cells by transfection. After 24 h of culture, transfected cells were exposed to heat shock at 40 or 42°C for 60 min. GFP expression was studied using fluorescent microscope Olympus IX81 with a blue excitation filter and a yellow blocking filter (Fig.10) and flow cytometry (Fig. 11 A).
GFP expression was observed in both cultures 24 h after the exposure to heat shock at 40°C. A fraction of studied cells exposed to heat shock was fixed with 4% formaldehyde to evaluate GFP fluorescence using flow cytometry on a FACScan (Fig. 11 A). The flow cytometry data demonstrated fluorescence of the GDNF/GFP fusion protein 24 h after heat shock at 40°C. Note that the effect of HSE number on the promoter induction was not very pronounced: four HSEs, 30.3% fluorescent cells; eight HSEs, 43% fluorescent cells. However, the proportion of fluorescent cells notably increased 48 h after heat shock. Cells transfected with B7/Gdnf/gfp (with four HSEs) demonstrated a substantial increase in the proportion of fluorescent cells: from 30.3 to 82.2%. The temperature of 42°C proved less efficient for the induction of GDNF/GFP expression in the case of both four and eight HSEs. However, the difference leveled off 48 h after heat shock (51% in the case of 40°C and 53% in the case of 42°C) (Fig. 6B).
GFP expression decreases 72 h after heat shock. However, repeated heat shock reactivates the protein expression.
Behavior of Transfected HEK293 Cells in Mouse Brain
Two series of experiments were carried out to study the behavior of cells transfected with B7 and F7. In the first series, HEK293 cells transfected with GFP-expressing B7 and F7 vectors with the regulated Drosophila hsp70 promoter were exposed to heat shock at 42°C for 60 min and transplanted into the mouse striatum. After 1, 3, 5, and 10 days, GFP-positive cells were visualized on the sections of the brain in the area of transplantation under a fluorescent microscope (Fig. 11B). The number of GFP-positive cells peaked 24 h after injection and decreased with time. No fluorescent cells were found on the mouse stratum sections 10 days after transplantation. No significant differences in the percentage of cells positive for GFP) have been revealed between cells transfected with B7/Gdnf/gfp and F7/Gdnf/gfp.
In the second series, transgenic HEK293/B7/gfp and HEK293/F7/gfp cells were introduced into the brain of mouse with experimental focal cerebral ischemia induced by endothelin-1. Immediately after the injection of this vasoconstrictor, a suspension of about 100,000 cells in 1 µl of Hanks solution was injected to the same site and depth. Prior to injection, the cells were not exposed to heat shock. In control animals the cells were injected without preliminary endothelin-1 administration.
These experiments demonstrated numerous transgenic cells in the injection area 24 h after transplantation. Only single GFP-positive cells were observed in the injection area 3 days later. Much more GFP-positive cells were found outside the injection area. Most cells were near vessels or the cerebral white matter (Fig. 11C, D). A minor fraction of cells were in the first layer of the cerebral cortex. Five days after the injection, only small numbers of GFP-positive cells could be found on brain sections in the injection area. Only individual cells (1–2 per section) could be found on the brain sections of control animals injected with transfected cells without preliminary endothelin-1 administration (Fig. 12).
Discussion
As demonstrated previously, D. melanogaster hsp70 promoter introduced into mammalian cells can function as a temperature-dependent promoter [18], [19]. In this work, cells were exposed to 45°C to activate the promoter. Schweinfest used transgenic mammalian cells expressing c-myc under control of the D. melanogaster hsp70 to demonstrate the activation of the promoter and transgene expression at 42°C [20]. Our experiments [8] showed that the temperature of hsp70 promoter activation can be decreased to 37°C if the same cells were transfected with a construct containing the HSP90 gene under control of the CMV promoter. Hence, there are mechanisms that can be used to decrease the temperature threshold for D. melanogaster hsp70 promoter activation. Andreeva with coauthors demonstrated that Drosophila hsp70 promoter activity does not necessarily correspond to the heat shock temperature of transfected species [21]. For instance, the transfection of a construct with Drosophila hsp70 promoter into loach embryonic cells led to the constitutive expression of promoter-controlled GFP irrespective of culture temperature. Thus, temperature regulation of Drosophila hsp70 promoter depends on the regulatory proteins of the host cell. Our experiments demonstrated that the number of HSEs at the 5′-end of the Drosophila hsp70 promoter modulates its sensitivity and activation duration. We have elected to use four and eight HSEs considering that the promoter regions of hsp70 in D. virilis and D. lummei contain two HSEs each, while the D. melanogaster promoter has four HSEs [14], [22], [23]. At the same time, the human heat shock promoter contains 1 to 3 HSEs [24], [25], [26]. Commonly there are two HSEs in humans, and HSE number increased by one improves the promoter response to heat shock. Our experiments with B7 and F7 vectors containing four and eight HSEs at the 5′-end of the Drosophila promoter, respectively, demonstrated the F7 promoter activation already at 38°C in human cells (Fig. 6), and its activity in this construct at higher temperatures was much higher compared to B7. HSE number increased to eight not only significantly improved the activation of the D. melanogaster hsp70 promoter but also shortened the period before reaching the peak promoter activity after heat shock. In the case of four HSEs at the 5′-end of the promoter, its activity peaked 48 h after heat shock and this peak was half that of the promoter with eight HSEs; moreover, the latter was already observed after 24 h and is maintained for 48 h (Fig. 6).
Transplantation of transgenic HEK293/B7 and HEK293/F7 cells into the mouse brain parenchyma demonstrated promoter activation and long-term GFP expression in the ischemic focus without heat shock prior to transplantation. Thus, both constructs can be activated by heat shock and likely by inflammatory processes in the brain ischemic focus, where GFP expression was observed for at least three days.
Further investigation of the activity of constructs used in this work should determine the applicability of Drosophila hsp70 promoter combined with different number of HSEs in the upstream region as a regulated promoter in genetic therapeutic systems.
Acknowledgments
Experiments were performed using the equipment of the IGB RAS facilities. We appreciate to Vladimir E. Babiy for administration.
Data Availability
The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files
Funding Statement
This work was supported by Russian Foundation for Basic Research (project nos. 13-04-40200H, 13-00-40200K) and Program "Molecular and Cell Biology". Experiments were performed using the equipment of the IGB RAS facilities supported by the Ministry of Science and Education of the Russian Federation (grants 16.552.11.7067). The authors express appreciation to Vladimir E. Babiy for administration and funding. Authors N. Kust, E. Rybalkina, A. Revishchin, E. Savchenko and G. Pavlova are employed by Ltd Apto-pharm who provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.
References
- 1.Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, et al. (2010) Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS One 5: : e10611, 1–4. doi: 10.1371/journal.pone.0010611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Hong S1, Hwang DY, Yoon S, Isacson O, Ramezani A, et al (2007) Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther 15(9): 1630–1639 10.1038/sj.mt.6300251 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Xiong W, Goverdhana S, Sciascia SA, Candolfi M, Zirger JM, et al. (2006) Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J Virol 80(1): 27–37 10.1128/JVI.80.1.27-37.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F (2009) In vivo gene regulation using tetracycline-regulatable systems. Adv Drug Deliv Rev 261(7–8): 527–541 10.1016/j.addr.2008.12.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Latta-Mahieu M1, Rolland M, Caillet C, Wang M, Kennel P, et al (2002) Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum Gene Ther 13(13): 1611–1620 10.1089/10430340260201707 [DOI] [PubMed] [Google Scholar]
- 6. Favre D, Blouin V, Provost N, Spisek R, Porrot F, et al. (2002) Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 76(22): 11605–11611 10.1128/JVI.76.22.11605-11611.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Korochkin LI (2000) New approaches in developmental genetics and gene therapy: xenotransplantation of Drosophila embryonic nerve cells into the brain of vertebrate animals. Genetika 36(11): 1436–1442. [PubMed] [Google Scholar]
- 8. Pavlova GV, Manuilova ES, Arsen'eva EL, Grivennikov IA, Murkin E, et al. (2005) BFP protein expression in transfected embryonic stem cells. Bull Exp Biol Med 139(4): 514–516 10.1007/s10517-005-0333-z [DOI] [PubMed] [Google Scholar]
- 9. Schlesinger MJ (1986) Heat shock proteins: The search for functions. J Cell Biol 103(2): 321–325 10.1083/jcb.103.2.321 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Dienel GA, Diessling M, Jaceqicz M, Pulsinnelli WA (1986) Synthesis of heat shock proteins in rat brain cortex after transient ischemia. J Cereb Blood Flow Metab 6(4): 505–510 10.1038/jcbfm.1986.86 [DOI] [PubMed] [Google Scholar]
- 11. Kennedy PG, LaThangue NB, Chan WL, Clements GB (1985) Cultured human neural cells accumulate a heat shock protein during acute herpes simplex virus infection. Neurosci Lett 61: 321–326 10.1016/0304-3940(85)90484-7 [DOI] [PubMed] [Google Scholar]
- 12. Pelham HR, Bienz M (1982) A synthetic heat-shock promoter element confers heat-inducibility on the herpes simplex virus thymidine kinase gene. EMBO J 1(11): 1473–1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Bienz M, Pelham HR (1987) Mechanisms of heat-shock gene activation in higher eukaryotes. Adv Genet 24: 31–72 10.1016/S0065-2660(08)60006-1 [DOI] [PubMed] [Google Scholar]
- 14. Amin J, Ananthan J, Voellmy R (1988) Key features of heat shock regulatory elements. Mol Cell Biol 8(9): 3761–3769 10.1128/MCB.8.9.3761 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fernandes M, O'Brien T, Lis JT (1994) Structure and regulation of heat shock gene promoters. In The Biology of Heat Shock Proteins and Molecular Chaperones (ed. R. I. Morimoto, A. Tissieres and C. Georgopoulos) 375–393. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
- 16. Wei R, Wilkinson H, Pfeifer K, Schneider C, Young R, et al. (1986) Two or more copies of Drosophila heat shock consensus sequence serve to activate transcription in yeast. Nucleic Acid Res 14(20): 8163–8188 10.1093/nar/14.20.8183 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Xiao H, Perisic O, Lis JT (1991) Cooperative binding of Drosophila heat shock factor to arrays of a conserved 5 bp unit. Cell 64(3): 585–593 10.1016/0092-8674(91)90242-Q [DOI] [PubMed] [Google Scholar]
- 18. Corces V, Pellicer A, Axel R, Meselson M (1981) Integration, transcription, and control of a Drosophila heat shock gene in mouse cells. Proc Natl Acad Sci U S A 78(11): 7038–7042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Corces V, Pellicer A (1984) Identification of sequences involved in the transcriptional control of a Drosophila heatshock gene. J Biol Chem 259(23): 14812–14817. [PubMed] [Google Scholar]
- 20. Schweinfest CW, Jorcyk CL, Fujiwara S, Papas TS (1988) A heat-shock-inducible eukaryotic expression vector. Gene 71(1): 207–210. [DOI] [PubMed] [Google Scholar]
- 21. Andreeva LE, Khai˘darova NV, Sleptsova LA, Rodriges-Blanko EV, Dicheva MA, et al. (2008) The effect of regulatory sequences of alphaS1-casein gene on the expression of the lacZ-gene in loach Misgurnus fossilis L. transgenic embryos. Genetika 44: 992–999. [PubMed] [Google Scholar]
- 22. Xiao H, Lis JT (1988) Germline transformation used to define key features of the heat shock response element. Science 239(4844): 1139–1142 10.1126/science.3125608 [DOI] [PubMed] [Google Scholar]
- 23. Xiao H, Lis JT (1989) Heat shock and developmental regulation of the Drosophila melanogaster hsp83 gene. Mol Cell Biol 9(4): 1746–1753 10.1128/MCB.9.4.1746 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Wilkerson DC, Skaggs HS, Sarge KD (2007) HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones 12(3): 283–290 10.1379/CSC-250.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Wu C (1995) Heat Shock Transcription Factors: Structure and Regulation. Annu Rev Cell Dev Biol 11: 441–469 10.1146/annurev.cb.11.110195.002301 [DOI] [PubMed] [Google Scholar]
- 26. Abravaya K, Phillips B, Morimoto RI (1991) Heat shock-induced interactions of heat shock transcription factor and the human hsp70 promoter examined by in vivo footprinting. Mol Cell Biol 11(1): 586–592 10.1128/MCB.11.1.586 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files